CEREVEL THERAPEUTICS HLDNG I

CUSIP: 15678U128 Class: Common Stock

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q2 2024
Shares 7,154,343 Value ($000) $292,541 Avg Close Range
Q1 2024
Shares 7,463,911 Value ($000) $315,500 Avg Close Range
Q4 2023
Shares 7,374,970 Value ($000) $312,699 Avg Close Range
Q3 2023
Shares 6,371,376 Value ($000) $139,087 Avg Close Range
Q2 2023
Shares 5,662,550 Value ($000) $180,012 Avg Close Range
Q1 2023
Shares 6,126,580 Value ($000) $149,427 Avg Close Range
Q4 2022
Shares 6,038,461 Value ($000) $190,453 Avg Close Range
Q3 2022
Shares 5,874,001 Value ($000) $165,999 Avg Close Range
Q2 2022
Shares 5,012,420 Value ($000) $132,529 Avg Close Range
Q1 2022
Shares 4,809,693 Value ($000) $168,388 Avg Close Range
Q4 2021
Shares 4,801,837 Value ($000) $155,677 Avg Close Range
Q3 2021
Shares 4,693,159 Value ($000) $138,448 Avg Close Range
Q2 2021
Shares 3,524,716 Value ($000) $90,304 Avg Close Range
Q1 2021
Shares 3,228,141 Value ($000) $44,323 Avg Close Range
Q4 2020
Shares 3,146,074 Value ($000) $52,162 Avg Close Range